Harvard Bioscience Inc. (HBIO) Shares Up 1.6%
Shares of Harvard Bioscience Inc. (NASDAQ:HBIO) shot up 1.6% during trading on Friday . The stock traded as high as $2.64 and last traded at $2.60, with a volume of 66,234 shares trading hands. The stock had previously closed at $2.56.
Separately, Zacks Investment Research cut Harvard Bioscience from a “hold” rating to a “sell” rating in a report on Tuesday, August 2nd.
The firm’s market capitalization is $89.90 million. The company’s 50 day moving average is $2.84 and its 200-day moving average is $2.99.
Harvard Bioscience (NASDAQ:HBIO) last announced its earnings results on Thursday, July 28th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.03. The business had revenue of $26.10 million for the quarter, compared to analysts’ expectations of $26.60 million. Equities analysts anticipate that Harvard Bioscience Inc. will post $0.16 earnings per share for the current fiscal year.
Harvard Bioscience, Inc is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company’s products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.